Alex

Last week, CMS updated guidance on the heavily disputed aspects of an arbitration process for resolving payment disagreements between insurers and providers under the No Surprises Act. The updates to this guidance were made in response to a Texas ruling that compelled HHS to change how dispute resolution entities would approach the pricing benchmark known …

New Surprise Billing Arbitration Guidance May Give Docs More Wiggle Room Read More »

Adding high-dose treosulfan and melphalan as further consolidation therapy for high-risk metastatic Ewing sarcoma failed to improve survival outcomes, a randomized phase III study showed. In an intention-to-treat population of 109 patients receiving standard induction and consolidation therapy, no significant difference was seen in event-free survival (EFS) between a group that also received high-dose treosulfan-melphalan …

Consolidation Intensification Fails in High-Risk Metastatic Ewing Sarcoma Read More »

Severity of multiple sclerosis (MS) was linked with geographic latitude, an observational study showed. Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who lived above 40° latitude, reported Tomas Kalincik, MD, PhD, of the University of Melbourne, Australia, and co-authors. The association was driven mainly, but not exclusively, …

More Severe Multiple Sclerosis Seen Further North Read More »

A bill recently passed by the House and under consideration in the Senate caps insulin payments at $35 a month for individuals with Medicare or private health insurance. The legislation speaks directly to the crisis in affordability for a life-saving medicine, but in the long term it is just shuffling the deck rather than changing …

Who Is Really Driving Up Insulin Costs? Read More »